Anavex Life Sciences Corp (AVXL)

[nidan7500]

This group of patients ( AVATAR) patients 18 years and older with RTT) may present a spectrum of change unlike any other (before/after). What an amazing moment they and their families may (hopefully)experience. IDNK who chose this grouping or why but can see a vast spectrum of life changing CNS disease drama. Bless them and best wishes it goes well for everyone.

Wonder if Dr. H. will comment.

ANAVEX2-73-RS-002 is a Phase 2, double-blind, randomized, placebo-controlled dose escalation safety, tolerability and efficacy study in patients 18 years and older with RTT using endpoints including multiple clinical and exploratory molecular and biochemical measures.

ANAVEX2-73 Study in Patients With Rett Syndrome (AVATAR)

Estimated Primary Completion Date : January 31, 2021
Estimated Study Completion Date : February 28, 2021


https://clinicaltrials.gov/ct2/show/NCT03941444